Early treatment prevents neuronal loss in experimental status epilepticus: A magnetic resonance spectroscopic imaging study

Abstract Objective In status epilepticus there are concerns that the prolonged high‐intensity electrographic seizure activity causes neuronal death and poorer outcomes. In animal models of status epilepticus, early treatment that stops the seizures prevents the later development of epilepsy. We wished to determine if that same treatment prevents the neuronal damage that is associated with the prolonged seizures and later epilepsy. Methods In adult male rats, status epilepticus was induced by continuous electrical stimulation of the hippocampus. Some rats received phenobarbital to stop the seizure activity. They were compared to rats that did not receive treatment. At set intervals after status epilepticus (1 week and 8 weeks) the rats were examined for N‐acetyl aspartate (NAA) concentrations, a biochemical marker for neurons, in selected brain regions with magnetic resonance spectroscopic imaging. Results Rats treated with phenobarbital had no decrease in NAA levels compared to untreated controls, which had significant decreases in the examined limbic regions. The decreases corresponded with neuronal loss seen by histological evalutation of the ventral hippocampus, olfactory cortex, and amygdala but not in the neocortex. Significance This study shows that early intervention to stop the status epilepticus prevents the neuronal loss that is associated with the development of epilepsy. The findings reinforce the principle of early and aggressive treatment for status epilepticus to improve long‐term outcomes. The findings support recent clinical reports that tie early, aggressive treatment to improved neurological outcomes.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2026-09-19
DOI
https://doi.org/10.1002/epi.70448
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Early treatment prevents neuronal loss in experimental status epilepticus: A magnetic resonance spectroscopic imaging study

Edward H. Bertram, Ye Chen, Erik J. Fernandez
Epilepsia
Neuroscience and Neuropharmacology Research
article

Early treatment prevents neuronal loss in experimental status epilepticus: A magnetic resonance spectroscopic imaging study

Edward H. Bertram, Ye Chen, Erik J. Fernandez
article en

Abstract

Abstract Objective In status epilepticus there are concerns that the prolonged high‐intensity electrographic seizure activity causes neuronal death and poorer outcomes. In animal models of status epilepticus, early treatment that stops the seizures prevents the later development of epilepsy. We wished to determine if that same treatment prevents the neuronal damage that is associated with the prolonged seizures and later epilepsy. Methods In adult male rats, status epilepticus was induced by continuous electrical stimulation of the hippocampus. Some rats received phenobarbital to stop the seizure activity. They were compared to rats that did not receive treatment. At set intervals after status epilepticus (1 week and 8 weeks) the rats were examined for N‐acetyl aspartate (NAA) concentrations, a biochemical marker for neurons, in selected brain regions with magnetic resonance spectroscopic imaging. Results Rats treated with phenobarbital had no decrease in NAA levels compared to untreated controls, which had significant decreases in the examined limbic regions. The decreases corresponded with neuronal loss seen by histological evalutation of the ventral hippocampus, olfactory cortex, and amygdala but not in the neocortex. Significance This study shows that early intervention to stop the status epilepticus prevents the neuronal loss that is associated with the development of epilepsy. The findings reinforce the principle of early and aggressive treatment for status epilepticus to improve long‐term outcomes. The findings support recent clinical reports that tie early, aggressive treatment to improved neurological outcomes.

Epilepsia
University of Virginia (US)
No poverty
Openalex Percentile: Top 16%
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.